Jennifer Decker, DPM
Podiatrist · Enterprise, ALNPI 1104092113
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $930 of the $1,197 with a category attached, or 77.7%. 11 manufacturers reported payments, led by Treace Medical Concepts, Inc. at 26.6% of the total. Reporting peaked in 2024 at $561 and has fallen 66.9% since, to $186 in 2025. That places this record below the midpoint for podiatrist clinicians in AL, where the typical reported total is $1,120.
Across 38 payments — averaging $31.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Treace Medical Concepts, Inc.$319
- Organogenesis Inc.$291
- Amgen$158
- Nevro Corp.$140
- Kerecis Limited$91
- Stryker$84
- plus $114 from 5 others
What the payments were for
- Travel & lodging$26622%
- Food & beverage$93078%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Treace Medical Concepts, Inc. | 4 | $319 |
| Organogenesis Inc. | 16 | $291 |
| Amgen | 3 | $158 |
| Nevro Corp. | 7 | $140 |
| Kerecis Limited | 1 | $91 |
| Stryker | 2 | $84 |
| Bioventus LLC | 1 | $40 |
| Smith+Nephew | 1 | $25 |
| Convatec Inc. | 1 | $21 |
| GSK | 1 | $14 |
| IBSA Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,197 in reported general payments places this provider in the 50th percentile of 59 podiatrist providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 98 | $6,460 |
| Ciclopirox | 103 | $4,567 |
| Gabapentin | 128 | $1,042 |
| Pregabalin | 23 | $792 |
| Ammonium Lactate | 39 | $737 |
| Nystatin | 57 | $569 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 42 | $525 |
| Triamcinolone Acetonide | 32 | $422 |
| Doxycycline Hyclate | 32 | $395 |
| Ketoconazole | 16 | $376 |
| Mupirocin | 38 | $355 |
| Terbinafine Hcl | 28 | $256 |
| SsdSilver Sulfadiazine | 27 | $194 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 17 | $185 |
| Silver Sulfadiazine | 12 | $111 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Enterprise
- Michael HamesFlorence$100K
- James MorganMobile$21K
- John RobersonBirmingham$10K
- Kyle MaukBirmingham$10K
- Johnnie AlstonMontgomery$9K
- Heidi ChristieMontgomery$7K
- Brent HaverstockBirmingham$7K
- David LindeBirmingham$6K
- Robert OcampoCullman$5K
- Jamie ClecklerBirmingham$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.